Extent, patterns, and burden of uncontrolled disease in severe or difficult‐to‐treat asthma

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Allergy. European Journal of Allergy and Clinical Immunology

• Publication date

  2007-02-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1111/j.1398-9995.2006.01254.xPMID 17298420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma

  2007cited by this paper
• Socioeconomic status and inflammatory processes in childhood asthma: the role of psychological stress.

  2006cited by this paper
• Assessing Productivity Impairment in Patients with Severe or Difficult-to-Treat Asthma: Validation of the Work Productivity Activity Impairment - Asthma Questionnaire

  2006cited by this paper
• Obtaining optimal control in mild asthma: theory and practice.

  2005cited by this paper
• Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study.

  2004influential reference
• Control and exacerbation of asthma: a survey of more than 3000 French physicians

  2004cited by this paper
• Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma.

  2004influential reference
• Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation, 2nd Edn. Haddix A, Teutsch SM, Corso PS. Oxford: Oxford University Press, 2003, pp. 264, £32.50 (HB) ISBN: 0-19-514897-5.

  2003cited by this paper
• Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study.

  2003cited by this paper
• A comprehensive study of the direct and indirect costs of adult asthma.

  2003cited by this paper
• Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma.

  2003cited by this paper
• Costs of occupational COPD and asthma.

  2002cited by this paper
• Inadequate use of asthma medication in the United States: results of the asthma in America national population survey.

  2002cited by this paper
• A national study of medical care expenditures for respiratory conditions

  2002cited by this paper
• National Asthma Education and Prevention Program.

  2002cited by this paper
• Achieving guideline-based asthma control: does the patient benefit?

  2002cited by this paper
• Association of asthma control with health care utilization: a prospective evaluation.

  2002cited by this paper
• Is overall asthma control being achieved? A hypothesis-generating study.

  2001cited by this paper
• Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study.

  2001cited by this paper
• Health economics of asthma and rhinitis. II. Assessing the value of interventions.

  2001cited by this paper
• The health economics of asthma and rhinitis. I. Assessing the economic impact.

  2001cited by this paper
• Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population.

  2001cited by this paper
• Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study.

  2000cited by this paper
• Trends in the cost of illness for asthma in the United States, 1985-1994.

  2000cited by this paper
• Asthma: an analysis of high-cost patients.

  2000cited by this paper
• Direct and indirect costs of asthma to an employer.

  2000cited by this paper
• Lack of correlation of symptoms with specialist-assessed long-term asthma severity.

  1999cited by this paper
• Association of asthma control with health care utilization and quality of life.

  1999cited by this paper
• Asthma's impact on society : the social and economic burden

  1999cited by this paper
• The cost of asthma in the emergency department and hospital.

  1999cited by this paper
• Development and validation of the Mini Asthma Quality of Life Questionnaire.

  1999cited by this paper
• Prevention effectiveness: A guide to decision analysis and economic evaluation

  1997cited by this paper
• A national estimate of the economic costs of asthma.

  1997cited by this paper
• Work, Classroom and Activity Impairment Instruments

  1996cited by this paper
• GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

  1996cited by this paper
• An economic evaluation of asthma in the United States.

  1992cited by this paper
• Standardized lung function testing.

  1984cited by this paper
• Standardized lung function testing. Report working party.

  1983cited by this paper
• Lung biology in health and disease

  1977cited by this paper
• Pulmonary Function Testing in Children: Techniques and Standards.

  1971cited by this paper
• Doubling the Dose of Inhaled Corticosteroid to Prevent Asthma Exacerbations: Randomised Controlled Trial Cost-effectiveness Analysis of Early Intervention with Budesonide in Mild Persistent Asthma

  year unknowncited by this paper

• Detection and prediction of real-world severe asthma phenotypes by application of machine learning to electronic health records

  2025cites this paper
• Management and Research Progress of Severe Asthma in China

  2025cites this paper
• Prevalence and Overlap of Treatable Traits in Severe Asthma and COPD: A Cross-Disease Comparison in a Tertiary Care Setting.

  2025cites this paper
• Astım Hastalığının Küresel Ekonomik Yükü: Sistematik Derleme ve Meta Analiz Çalışması

  2025cites this paper
• Targeted treatment in asthma - opportunities and challenges.

  2025cites this paper
• Costs of Presenteeism and Absenteeism Associated With Psychological Distress Among Male and Female Older Workers

  2024cites this paper
• The Path to Diagnosis of Severe Asthma-A Qualitative Exploration

  2024cites this paper
• Allergen immunotherapy in Italy: How, when, and why—A real-world study conducted through a patient association

  2024cites this paper
• Comparative efficacy of biologics for patients with inadequately controlled asthma: A network meta-analysis

  2024cites this paper
• Environmental Effects on the Prevalence of Allergies

  2024cites this paper
• Biologic therapies targeting type 2 cytokines are effective at improving asthma symptoms and control—a systematic review and meta-analysis

  2024cites this paper
• Endobronchial Ultrasound is Useful in the Assessment of Bronchial Wall Changes Related to Bronchial Thermoplasty

  2023cites this paper
• Nationwide trends in hospitalization, medical costs, and mortality for asthma after introduction of biologics: A cross-sectional study in the United States

  2023cites this paper
• Epidemiology of Asthma: Prevalence and Burden of Disease.

  2023cites this paper
• Bioinformatic analysis and experimental validation of the potential gene in the airway inflammation of steroid-resistant asthma

  2023cites this paper
• The Saudi initiative for asthma – 2024 update: Guidelines for the diagnosis and management of asthma in adults and children

  2023cites this paper
• The Association of Medicaid expansion with prescription drug utilization and expenditure among low-income participants with asthma

  2023cites this paper
• Comorbid allergic rhinitis and asthma: important clinical considerations

  2022cites this paper
• TFR1 expression in induced sputum is associated with asthma severity

  2022cites this paper
• Severe asthma in children: Description of a large multidisciplinary clinical cohort

  2022cites this paper
• Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis.

  2022cites this paper
• Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis.

  2022cites this paper
• FeNO in Asthma.

  2022cites this paper
• Economic burden of severe asthma treatment: A real-life study

  2022cites this paper
• A Paradigm Shift for Asthma Care.

  2022cites this paper
• Clinical and Economic Burden of Severe Asthma Among US Patients Treated with Biologic Therapies.

  2021cites this paper
• The Saudi Initiative for Asthma - 2021 Update: Guidelines for the diagnosis and management of asthma in adults and children

  2021cites this paper
• Mapping Geographic Variability of Severe Uncontrolled Asthma in the United States: Management Implications.

  2021cites this paper
• Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for people with asthma.

  2021cites this paper
• The severe asthma registries : a way to better know and fight the disease Severe asthma management in the era of biologics : insights of the Italian Registry on Severe Asthma ( IRSA ) Immune signature

  2021cites this paper
• GLCCI1 gene body methylation in peripheral blood is associated with asthma and asthma severity.

  2021cites this paper
• Machine learning and in silico methods

  2021cites this paper
• Metabolism of Epithelial Cells in Health and Allergic Disease: Collegium Internationale Allergologicum Update 2021

  2021cites this paper
• Oxidative Stress Promotes Corticosteroid Insensitivity in Asthma and COPD

  2021cites this paper
• Positive change in asthma control using therapeutic patient education in severe uncontrolled asthma: a one-year prospective study

  2021cites this paper
• RMHP_A_211321 43..53

  2020cites this paper
• The impact of patient self-monitoring via electronic medication monitor and mobile app plus remote clinician feedback on adherence to inhaled corticosteroids: A randomized controlled trial.

  2020cites this paper
• Insights Into Type I and III Interferons in Asthma and Exacerbations

  2020cites this paper
• The cost-effectiveness of azithromycin in reducing exacerbations in uncontrolled asthma

  2020cites this paper
• Economic burden of severe asthma in Turkey: a cost of illness study from payer perspective.

  2020cites this paper
• Epidemiological, clinical and economic burden of severe eosinophilic asthma in Taiwan: Results from a large tertiary care hospital

  2020cites this paper
• Prevalence of asthma at a school-based health clinic in Nicaragua.

  2020cites this paper
• Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study

  2020cites this paper
• Pediatric use of omalizumab for allergic asthma

  2020cites this paper
• Asthma Biologics: Comparing Trial Designs, Patient Cohorts and Study Results.

  2020cites this paper
• Severe Asthma and Allergy: A Pediatric Perspective

  2019cites this paper
• “…I've said I wish I was dead, you'd be better off without me”: A systematic review of people's experiences of living with severe asthma

  2019cites this paper
• Novel Biological Therapies in Severe Asthma: Targeting the Right Trait.

  2019cites this paper
• High IFN-g and low SLPI mark severe asthma in mice and humans

  2019influential citation
• The impact of severe asthma on patients’ autonomy: A qualitative study

  2019cites this paper
• Regulation of IL-17A and implications for TGF-β1 comodulation of airway smooth muscle remodeling in severe asthma.

  2019cites this paper
• Comparing the effect of pulmonary rehabilitation in patients with uncontrolled and partially controlled asthma

  2019cites this paper
• Impact of Omalizumab on Food Allergy in Patients Treated for Asthma: A Real-Life Study.

  2019cites this paper
• Application of structured statistical analyses to identify a biomarker predictive of enhanced tralokinumab efficacy in phase III clinical trials for severe, uncontrolled asthma

  2019cites this paper
• Bronchoalveolar Lavage Cell Gene Expression in Severe Asthma Reveals Mechanisms of Severe Disease and Influences of Medications.

  2019cites this paper
• BAL Cell Gene Expression in Severe Asthma Reveals Mechanisms of Severe Disease and In fl uences of Medications

  2019influential citation
• The Saudi Initiative for Asthma - 2019 Update: Guidelines for the diagnosis and management of asthma in adults and children

  2019cites this paper
• Estimated cost of asthma in outpatient treatment: a real-world study

  2018cites this paper
• Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma

  2018cites this paper
• Estimating asthma control questionnaire (ACQ) scores from claims data

  2018cites this paper
• Severe Bronchial Asthma in the era of biological treatments

  2018cites this paper
• Estimativa de custo da asma em tratamento ambulatorial: estudo com dados de mundo real

  2018cites this paper
• Economic Burden of Adult Asthma in Turkey: A Cost of Illness Study from Payer Perspective

  2018cites this paper
• Obese- and allergic-related asthma phenotypes among children across the United States

  2018cites this paper
• Working while unwell: Workplace impairment in people with severe asthma

  2018cites this paper
• Chinese expert consensus on diagnosis and management of severe asthma.

  2018cites this paper
• Immune Dysregulation in Children with Allergic Asthma: A Close Relationship Between IL-17 but not IL-4 or IFN-

  2018cites this paper
• Horses With Pasture Asthma Have Airway Remodeling That Is Characteristic of Human Asthma

  2018cites this paper
• TREATMENT ADHERENCE OF ASTHMA PATIENTS IN LATVIA AND FACTORS RELATED TO ADHERENCE

  2018cites this paper
• Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations

  2018cites this paper
• Basophil Membrane Expression of Epithelial Cytokine Receptors in Patients with Severe Asthma

  2018cites this paper
• Drug repurposing to treat asthma and allergic disorders: Progress and prospects

  2018cites this paper
• Severe asthma: Current management, targeted therapies and future directions—A roundtable report

  2017cites this paper
• Factors Predicting Corticosteroid Inhaled Adherence in Patients with Asthma

  2017cites this paper
• Factors leading to refractory asthma in patients from Saudi Arabia

  2017cites this paper
• Biomarqueurs systémiques associés à l'asthme persistant ou sévère de l'enfant

  2017cites this paper
• Rebuttal From Dr O'Byrne.

  2017cites this paper
• IgE and eosinophils as therapeutic targets in asthma

  2017cites this paper
• Asthma: definition, severity and impact of pulmonary exacerbations

  2017cites this paper
• Gene Expression Correlated with Severe Asthma Characteristics Reveals Heterogeneous Mechanisms of Severe Disease

  2017cites this paper
• Clinical and Economic Burden of Elevated Blood Eosinophils in Patients With and Without Uncontrolled Asthma.

  2017cites this paper
• Severe asthma and asthma-COPD

  2017cites this paper
• Novel monoclonal treatments in severe asthma

  2017cites this paper
• Severe asthma and asthma-COPD overlap: a double agent or identical twins?

  2017cites this paper
• Measuring the cost of poor asthma control and exacerbations

  2017cites this paper
• Accreditation of specialized asthma units for adults in Spain: an applicable experience for the management of difficult-to-control asthma

  2017cites this paper
• Asthma Control Assessment Tools

  2016cites this paper
• Sustainable Financing Models for Community Health Worker Services in Maine

  2016influential citation
• The Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children

  2016cites this paper
• Current concepts of severe asthma.

  2016cites this paper
• Asthma phenotypes in children and stratified pharmacological treatment regimens

  2016cites this paper
• Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma

  2016cites this paper
• Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting

  2016cites this paper
• Epidemiology and Pulmonary Physiology of Severe Asthma.

  2016cites this paper
• Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

  2016cites this paper
• Exploring asthma control cutoffs and economic outcomes using the Asthma Control Questionnaire.

  2016cites this paper
• Update on the current methods for the diagnosis and treatment of severe childhood asthma

  2015cites this paper
• Outcomes before and after treatment escalation to Global Initiative for Asthma steps 4 and 5 in severe asthma.

  2015cites this paper
• Psychopathology in difficult asthma

  2015cites this paper
• pathway is insensitive to glucocorticoid in airway

  2015cites this paper